Panel de control de cohortes

La misión del GP2 es comprender la arquitectura genética de la enfermedad de Parkinson (EP) mediante el genotipado de grupos de pacientes diversos y el estudio de formas de la EP de las cuales se sospecha que son monogénicas. Para apoyar esta misión, seguimos recopilando cohortes diversas de todo el mundo a través de la colaboración y compartiendo datos, procesos y resultados de manera abierta. Explore el siguiente panel de control, donde encontrará los logros alcanzados hasta la fecha, y vuelva a visitar esta página periódicamente, ya que actualizamos los datos trimestralmente.

Datos globales totales

0
Ubicaciones únicas
0
Cohortes
0
Muestras pendientes
0
Muestras completadas

Última actualización: 9 de septiembre del 2021 | Diseño original del equipo GP2 Hackathon 2021: Mary Makarious, Kajsa Brolin, Yeajin Song y Anastasia Illarionova

Showing 10 of 238 cohort studies.

GP2 - Bangladesh

National Institutes of Neuroscience & Hospital, Dhaka, Bangladesh | Dhaka, Bangladesh
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

GP2 - Fundación Diagnosis

Fundación Diagnosis | Santiago, Chile
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

33 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

33 Completed out of 100 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Koc University

Koc University | Istanbul, Turkey
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

80 Completed out of 200 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

80 Completed out of 200 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Koc University M

Koc University | Istanbul, Turkey
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

60 Completed out of 75 Expected
Non-PD Samples
Non-PD Samples

6 Completed out of 0 Expected
Total Samples
Total Samples

66 Completed out of 75 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Samsung

Samsung Medical Center | Seoul, South Korea
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 500 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 230 Expected
Total Samples
Total Samples

0 Completed out of 730 Expected

GP2 - Seoul National University Hospital

Seoul National University Hospital | Seoul, South Korea
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

280 Completed out of 280 Expected
Non-PD Samples
Non-PD Samples

1 Completed out of 0 Expected
Total Samples
Total Samples

281 Completed out of 280 Expected
Ancestry Breakdown for Samples Completed
Show

HAWAII PD

The Queen's Medical Center | Honolulu, United States
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 100 Expected
Total Samples
Total Samples

0 Completed out of 200 Expected

HIPDR

University of Miami | Miami, United States
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 140 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

0 Completed out of 140 Expected

ICEBERG

INSERM, French Institute of Health and Medical Research | Paris, France
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 180 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 70 Expected
Total Samples
Total Samples

0 Completed out of 250 Expected

IGECND

University of Kiel | Kiel, Germany
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

74 Completed out of 1,200 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

74 Completed out of 1,200 Expected
Ancestry Breakdown for Samples Completed
Show

Solicitar conjunto de datos de AMP-PD

Una vez que el GP2 completa el genotipado de una cohorte, todos los datos se comparten en la plataforma segura AMP® PD. Regístrese para solicitar acceso a estos datos.

Aportar una cohorte

Si desea colaborar con el GP2, póngase en contacto con nosotros para aportar una cohorte o infórmese sobre cómo hacerse miembro.

Conozca los miembros del GP2 de todo el mundo

Explore las organizaciones miembro que hacen que nuestra investigación sea posible gracias a su colaboración y contribución de muestras y datos.